Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07243873

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPET-CTA PET-CT scan is performed prior to initiating systemic treatment for the tumour.

Timeline

Start date
2025-12-01
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2025-11-24
Last updated
2025-11-24

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07243873. Inclusion in this directory is not an endorsement.